The patient with persistent alopecia in Group A received TC × 4, but was not administered hormonal agents, whereas of the patients with persistent alopecia in Group B, 3 received an aromatase inhibitor, 2 received tamoxifen at 13 months, and 2 were not administered hormonal agents (Supplementary Table 1). The gene discussed is CYP19A1; the disease is alopecia.